세계 백혈병 스크리닝 시장 : 검사 유형별, 질환 유형별, 연령층별, 최종 사용자별, 지역별

Global leukemia screening market is estimated to be valued at US$ 7.28 Bn in 2023 and is expected to reach US$ 11.66 Bn by 2030, exhibiting a compound annual growth rate (CAGR) of 7% during the forecast period.

Figure 1. Global Leukemia Screening Market Share (%), By Region, 2023

Leukemia is a type of cancer that affects blood cells. It is a serious condition that causes a high number of deaths, thereby creating a huge burden on families and the healthcare system. The main diagnostic tools for leukemia are laboratory tests and a physical exam. A complete blood count (CBC) checks the levels of red and white blood cells and platelets in the body. A high level of abnormal white cells can indicate leukemia. Some types of leukemia cells circulate in the blood, while others stay in the bone marrow and do not show up in a routine blood test. The global leukemia screening market has been witnessing notable growth over the past few years due to the rising incidence of different types of leukemia across the world. Leukemia is a type of blood cancer that starts in the bone marrow and results in a high number of abnormal white blood cells. There has been steady rise in leukemia cases due to growing environmental pollution, changing lifestyle habits, and increasing age of the population globally. As a consequence, demand for advanced screening tests for early detection of leukemia has increased in both developed and developing nations. Various public and private initiatives aimed at enhancing awareness about leukemia and availability of innovative screening solutions has further propelled the global leukemia screening industry.

Market Dynamics:

The market is expanding significantly as a result of factors such the increased prevalence of illnesses linked to legionella and pneumonia, as well as the growing need for quick, sophisticated diagnostic methods and developments in bacterial testing technology. A comparatively rare cause of community-acquired pneumonia is legionella pneumonia. For instance, in November 2022, according to a study published titled "Community-Acquired Pneumonia", the expected global incidence of community-acquired pneumonia ranges from 1.5 to 14 cases per 1000 person each year, with region, season, and population characteristics all having a part. Incidence rates rise with age, with 24.8 instances per 10,000 adults in the U.S. each year.

Key features of the study:

• This report provides in-depth analysis of the global leukemia screening market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global leukemia screening market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Thermo Fisher Scientific Inc., Sysmex Corporation, Bio-Rad Laboratories, Inc., QIAGEN N.V., Beckman Coulter, Inc., Adaptive Biotechnologies Corporation, Invivoscribe, Inc., and ArcherDX, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global leukemia screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global leukemia screening market

Detailed Segmentation:

• Global Leukemia Screening Market, By Test Type
  • Complete Blood Count (CBC)
  • Bone Marrow Aspiration and Biopsy
  • Flow Cytometry
  • Cytogenetic Analysis
  • Polymerase Chain Reaction (PCR)
  • Immunophenotyping
  • Others
• Global Leukemia Screening Market, By Disease Type
  • Acute Lymphoblastic Leukemia (ALL)
  • Acute Myeloid Leukemia (AML)
  • Chronic Lymphocytic Leukemia (CLL)
  • Chronic Myeloid Leukemia (CML)
  • Others
• By Age Group
  • Pediatric
  • Adult
  • Geriatric
• By End User
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • Others
• By Region
  • North America
  • Europe
  • Latin America
  • Middle East
  • Africa
• Top Companies in the Global Leukemia Screening Market:
  • F.Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Sysmex Corporation
  • Bio-Rad Laboratories, Inc.
  • QIAGEN N.V.
  • Beckman Coulter, Inc.
  • Adaptive Biotechnologies Corporation
  • Invivoscribe, Inc.
  • ArcherDX, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Test Type
  • Market Snippet, By Disease Type
  • Market Snippet, By Age Group
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increasing incidence of leukemia
  • High cost of screening procedures
  • Expansion in emerging markets
• Key Highlights
• Regulatory Scenario
• Recent Trends
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Mergers, Acquisitions, and Collaborations

4. Global Leukemia Screening Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Leukemia Screening Market, By Test Type, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Complete Blood Count (CBC)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Bone Marrow Aspiration and Biopsy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Flow Cytometry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Cytogenetic Analysis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Polymerase Chain Reaction (PCR)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Immunophenotyping
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Leukemia Screening Market, By Disease Type, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Acute Lymphoblastic Leukemia (ALL)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
• Acute Myeloid Leukemia (AML)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
• Chronic Lymphocytic Leukemia (CLL)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
• Chronic Myeloid Leukemia (CML)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )

7. Global Leukemia Screening Market, By Age Group, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Pediatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
• Adult
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
• Geriatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )

8. Global Leukemia Screening Market, By End User, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
• Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

9. Global Leukemia Screening Market, By Region, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Region, 2019-2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Bn)
• South Africa
• Central Africa
• North Africa

10. Competitive Landscape

• Company Profile
  • F.Hoffmann-La Roche Ltd
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Abbott Laboratories
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Thermo Fisher Scientific Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Sysmex Corporation
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Bio-Rad Laboratories, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • QIAGEN N.V.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Beckman Coulter, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Adaptive Biotechnologies Corporation
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Invivoscribe, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • ArcherDX, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Analyst Views

11. Section

• References
• Research Methodology
• About us